Esocuris-DSR

Esocuris-DSR Capsules by Biocuris is an advanced dual-action formulation containing Esomeprazole (Enteric Coated – 40mg) and Domperidone (Sustained Release – 20mg). Esomeprazole is the S-isomer of omeprazole and provides more consistent and predictable acid suppression than racemic omeprazole. It is a proton pump inhibitor (PPI) that irreversibly blocks the gastric H+/K+ ATPase enzyme, reducing both basal and meal-stimulated acid secretion. The enteric coating (EC) protects esomeprazole from degradation by stomach acid, ensuring it reaches the small intestine intact for optimal absorption. Clinical studies show esomeprazole 40mg provides superior healing rates for erosive esophagitis compared to omeprazole 20mg or 40mg. Domperidone is a prokinetic and antiemetic agent that blocks peripheral dopamine D2 receptors. It increases lower esophageal sphincter pressure, enhances gastric emptying, coordinates antroduodenal motility, and effectively controls nausea and vomiting. The sustained release (SR) technology ensures consistent domperidone levels over 12–24 hours with once-daily dosing.

This powerful combination is indicated for the treatment of gastroesophageal reflux disease (GERD), including erosive esophagitis (healing and maintenance), symptomatic GERD (heartburn, regurgitation, epigastric pain), non-erosive reflux disease (NERD), and Zollinger-Ellison syndrome. The addition of sustained-release domperidone makes it particularly effective for patients who experience significant nausea, vomiting, bloating, early satiety, or delayed gastric emptying along with acid-related symptoms.

Esomeprazole offers several advantages over other PPIs including higher bioavailability (90% vs. 50-60% for omeprazole), less inter-patient variability, fewer drug interactions (less CYP2C19 metabolism), and faster onset with more sustained 24-hour acid control. A single 40mg dose maintains intragastric pH >4 for approximately 17-18 hours.

Manufactured under Biocuris’s “Quality with Integrity” standard, each capsule delivers consistent potency and purity. The recommended dosage is one capsule once daily, taken 30–60 minutes before breakfast. Swallow the capsule whole with water; do not crush, chew, or open it. For patients with nocturnal reflux or breakthrough symptoms, your doctor may advise taking it before dinner. Store between 15°C to 30°C (59°F to 86°F) in a dry place away from direct sunlight.

Key Benefits

• Superior acid suppression vs. omeprazole

• Once-daily sustained relief for 24 hours

• Controls nausea, vomiting & bloating

• Heals erosive esophagitis faster

• Enteric-coated for targeted intestinal delivery

Frequently Asked Questions:

1. How is esomeprazole different from omeprazole or pantoprazole?
Esomeprazole is the S-isomer of omeprazole, providing higher bioavailability (90% vs 50%), more predictable acid control, and superior healing of erosive esophagitis.

2. What does DSR stand for in Esocuris-DSR?
DSR stands for Delayed + Sustained Release – esomeprazole is enteric-coated (delayed release), and domperidone is sustained release (prolonged action over 24 hours).

3. Can I take Esocuris-DSR if I have trouble swallowing capsules?
No, do not crush or open the capsule. Swallow it whole to preserve the enteric coating and sustained release mechanisms. Consult your doctor for alternatives.

4. How long does it take to heal erosive esophagitis with Esocuris DSR?
Esomeprazole 40mg once daily typically heals erosive esophagitis within 4–8 weeks, with most patients healed by 4 weeks.

5. Is it safe to take Esocuris-DSR with clopidogrel (blood thinner)?
Yes, esomeprazole has less interaction with clopidogrel compared to omeprazole, but consult your doctor as individual assessment is still recommended.